Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.

Development of solubility-enhancing formulations for poorly water-soluble compounds always poses a challenge. Conventional formulation screening assays are potentially time-consuming and labor-intensive and, moreover, require a large amount of a compound; they are not ideal when compound availability and testing time are limited. In recent years, in-vitro screening assays that are rapid, inexpensive, minimally labor-intensive, and require only small quantities of a compound have become available. These advanced assays allow high-throughput automation, miniaturization, and parallel processing, thereby enabling scientists to rapidly identify solubility-enhancing formulations with milligram or sub-milligram quantities of an active pharmaceutical ingredient (API). This article reviews these assays for rapidly screening the aqueous solubility of lead compounds and the solubility-enhancing formulations with limited quantities of API.

[1]  Jochem Alsenz,et al.  Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development , 2007, Pharmaceutical Research.

[2]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[3]  Alex Avdeef.  High‐Throughput Measurements of Solubility Profiles , 2007 .

[4]  A. Glomme,et al.  Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. , 2005, Journal of pharmaceutical sciences.

[5]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[7]  J. Dressman,et al.  Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.

[8]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[9]  W. Charman,et al.  Lipid-based vehicles for the oral delivery of poorly water soluble drugs , 1997 .

[10]  Jochem Alsenz,et al.  Development of a partially automated solubility screening (PASS) assay for early drug development. , 2007, Journal of pharmaceutical sciences.

[11]  C. Porter,et al.  In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.

[12]  Kiyohiko Sugano,et al.  High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.

[13]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  L. Takahashi,et al.  Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. , 2001, Journal of pharmaceutical sciences.

[15]  Chris McNulty,et al.  A High-Throughput Combinatorial Approach for the Discovery of a Cremophor EL-Free Paclitaxel Formulation , 2003, Pharmaceutical Research.

[16]  Jeong-Sook Park,et al.  Solubility enhancers for oral drug delivery , 2004 .

[17]  Thilo A Fligge,et al.  Integration of a rapid automated solubility classification into early validation of hits obtained by high throughput screening. , 2006, Journal of pharmaceutical and biomedical analysis.

[18]  H. Kristensen,et al.  Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Srini Venkatesh,et al.  Miniature Device for Aqueous and Non-aqueous Solubility Measurements During Drug Discovery , 2004, Pharmaceutical Research.

[20]  Shobha N. Bhattachar,et al.  Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery. , 2006, Journal of pharmaceutical and biomedical analysis.

[21]  E. Kerns,et al.  High throughput physicochemical profiling for drug discovery. , 2001, Journal of pharmaceutical sciences.

[22]  Tycho Heimbach,et al.  Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. , 2007, Journal of pharmaceutical and biomedical analysis.

[23]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[24]  W. Tong,et al.  Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.

[25]  B. Boyd,et al.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.

[26]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[27]  A. Hoffman,et al.  Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.

[28]  Karen A. Dehring,et al.  Automated robotic liquid handling/laser-based nephelometry system for high throughput measurement of kinetic aqueous solubility. , 2004, Journal of pharmaceutical and biomedical analysis.

[29]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  Christopher T. Walsh,et al.  Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.

[31]  Teng-Man Chen,et al.  Evaluation of a method for high throughput solubility determination using a multi-wavelength UV plate reader. , 2002, Combinatorial chemistry & high throughput screening.

[32]  Xinfeng Shi,et al.  Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME). , 2007, Journal of pharmaceutical sciences.

[33]  Michel Carpentier,et al.  Liquid chromatography-mass spectrometry with chemiluminescent nitrogen detection for on-line quantitative analysis of compound collections: advantages and limitations. , 2004 .

[34]  Jonathan Kenneth Embleton,et al.  Influence of lipolysis on drug absorption from the gastro-intestinal tract , 1997 .

[35]  Matt Peterson,et al.  Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..

[36]  Colin Gardner.  Drug candidate selection : The role of physical chemistry and material science in form and formulation , 2005 .

[37]  Jean-Francois Marier,et al.  A Novel, Lipid-Free Nanodispersion Formulation of Propofol and Its Characterization , 2005, Pharmaceutical Research.

[38]  Nagesh R Palepu,et al.  Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens. , 2003, International journal of pharmaceutics.

[39]  Anette Müllertz,et al.  Enzymatic characterization of lipid-based drug delivery systems. , 2005, International journal of pharmaceutics.

[40]  Gary Eichenbaum,et al.  Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing. , 2007, Journal of pharmaceutical sciences.

[41]  S. Walker,et al.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.

[42]  G. Edwards,et al.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.

[43]  Beate Bittner,et al.  Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters. , 2002, Current opinion in drug discovery & development.

[44]  J. Cheetham,et al.  An Automated Screening Assay for Determination of Aqueous Equilibrium Solubility Enabling SPR Study During Drug Lead Optimization , 2005 .

[45]  Weiyong. Li,et al.  Determination of topiramate and its degradation product in liquid oral solutions by high performance liquid chromatography with a chemiluminescent nitrogen detector. , 2005, Journal of pharmaceutical and biomedical analysis.

[46]  I. Mutton,et al.  Toward single-calibrant quantification in HPLC. A comparison of three detection strategies: evaporative light scattering, chemiluminescent nitrogen, and proton NMR. , 2005, Analytical chemistry.

[47]  Takashi Kajima,et al.  [Development of solubility screening methods in drug discovery]. , 2002, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[48]  C. Pouton,et al.  KEY ISSUES WHEN FORMULATING HYDROPHOBIC DRUGS WITH LIPIDS , 1999 .

[49]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[50]  Jing Chen,et al.  Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material. , 2007, International journal of pharmaceutics.

[51]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[52]  Jon Hilden,et al.  Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. , 2005, Journal of pharmaceutical sciences.

[53]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.